Amgen (AMGN) agrees to buy 95.6% of privately-held Turkish company Mustafa Nevzat...

|About: Amgen Inc. (AMGN)|By:, SA News Editor

Amgen (AMGN) agrees to buy 95.6% of privately-held Turkish company Mustafa Nevzat Pharmaceuticals for an amount that values the firm at $700M. The acquisition will help AMGN expand its operations in the fast-growing Turkish market and surrounding region (also: earnings). AMGN +1.3% premarket.